WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/061543    International Application No.:    PCT/SE2004/002007
Publication Date: 07.07.2005 International Filing Date: 21.12.2004
Chapter 2 Demand Filed:    15.06.2005    
C07K 16/06 (2006.01)
Applicants: GE HEALTHCARE BIO-SCIENCES AB [SE/SE]; Björkgatan 30, S-751 84 Uppsala (SE) (For All Designated States Except US).
GLAD, Gunnar [SE/SE]; (SE) (For US Only).
JOHANSSON, Bo-Lennart [SE/SE]; (SE) (For US Only).
MALOISEL, Jean-Luc [FR/SE]; (SE) (For US Only).
NORRMAN, Nils [SE/SE]; (SE) (For US Only)
Inventors: GLAD, Gunnar; (SE).
JOHANSSON, Bo-Lennart; (SE).
MALOISEL, Jean-Luc; (SE).
Agent: KILANDER, Annika; GE Healthcare Bio-Sciences AB, Patents Department, Björkgatan 30, S-751 84 Uppsala (SE)
Priority Data:
0303532-6 23.12.2003 SE
Abstract: front page image
(EN)The present invention relates to a separation matrix comprised of a porous support to which ligands have been immobilised, wherein said ligands comprise at least one aliphatic sulphonamide. The nitrogen of the sulphonamide may be a secondary or tertiary amine. The invention also relates to a chromatography column that contains the described separation matrix, as well as to a method of isolating immunoglobulin-like compounds by adsorption to a separation matrix that comprises aliphatic sulphonamide ligands.
(FR)L'invention concerne une matrice de séparation comprenant un support poreux sur lequel sont immobilisés des ligands, ces ligands comprenant au moins un sulfonamide aliphatique. L'azote du sulfonamide peut être une amine secondaire ou tertiaire. L'invention concerne aussi une colonne de chromatographie qui contient la matrice de séparation décrite, et un procédé d'isolement de composés du type immunoglobulines par adsorption sur une matrice de séparation comprenant des ligands à base de sulfonamide aliphatique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)